Volume 32, Issue 4 910729 pp. 241-246
Article
Open Access

Poly Thymidine Polymorphism and Cystic Fibrosis in a Non-Caucasian Population

Reza Tabaripour

Reza Tabaripour

Department of Biology Science and Research Branch Islamic Azad University Tehran, Iran , iau.ac.ir

Search for more papers by this author
Haleh Akhavan Niaki

Corresponding Author

Haleh Akhavan Niaki

Cellular and Molecular Biology Research Center Babol University of Medical Sciences Babol, Iran , mubabol.ac.ir

Search for more papers by this author
Mohammad Reza Esmaeeli Douki

Mohammad Reza Esmaeeli Douki

Non-Communicable Pediatric Diseases Research Center Babol University of Medical Sciences Babol, Iran , mubabol.ac.ir

Search for more papers by this author
Javad Tavakkoly Bazzaz

Javad Tavakkoly Bazzaz

Genetic Department of Tehran University of Medical Scienses Tehran, Iran , tums.ac.ir

Search for more papers by this author
Bagher Larijani

Bagher Larijani

Endocrine Research Center of Tehran University of Medical Sciences Tehran, Iran , tums.ac.ir

Search for more papers by this author
Parichehr Yaghmaei

Parichehr Yaghmaei

Department of Biology Science and Research Branch Islamic Azad University Tehran, Iran , iau.ac.ir

Search for more papers by this author
First published: 26 May 2013

Abstract

Background: Cystic fibrosis is a monogenic recessive disorder found predominantly in Caucasian population. This disease arises from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In this study we consider poly T polymorphism c.1210-12T[5], c.1210-12T[7], c.1210-12T[9] (T5, T7, T9) in the intron 8 of CFTR gene in normal individuals and cystic fibrosis patients in the north of Iran.

Material and methods: 40 CF patients and 40 normal individuals were screened for poly T polymorphism in intron 8 of CFTR gene using Reverse Dot Blot method which was also used to detect p.Phe508del among CF patients.

Results: T7 allele is the most prevalent in both normal and CF patients. Its abundance is approximately 75%. T9 and T5 represent approximately 20% and 5% of alleles respectively. T7/ T7 genotype is the most present in both normal and CF patients with 72.5% and 60% prevalence respectively. p.Phe508del was present in 13 CFTR alleles belonging to 7 patients with either homozygote T9/ T9, T7/ T7 or compound heterozygote T7/ T9 genotypes.

Conclusion: Contrary to the Caucasians, T7 allele is more frequent in Northern Iranian CF patients. The presence of p.Phe508del and T7 allele in the same framework is reported for the first time in this part of the world. Further investigations of other populations will help to understand whether p.Phe508del arose by selection pressure in this part of the world or was imported from European countries. The abundance of T5, T7, T9 alleles indicates that this polymorphism can be used as one of the informative markers for detection of normal and mutant alleles in prenatal diagnosis or carrier assessment in families with previous history of the disease in regions with high degree of CFTR mutation heterogeneity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.